Global Single Domain Antibody(sdAbs) Drugs Supply, Demand and Key Producers, 2026-2032
The global Single Domain Antibody(sdAbs) Drugs market size is expected to reach $ 1132 million by 2032, rising at a market growth of 11.6% CAGR during the forecast period (2026-2032).
Single Domain Antibody Drugs refer to approved and commercially marketed therapeutic drugs whose active molecules are based on single-domain antibody structures. The currently marketed products mainly include Sanofi's Cablivi, Taisho Pharmaceutical's Nanozora, and Envafolimab manufactured by Alphamab Oncology, covering indications such as acquired thrombotic thrombocytopenic purpura, rheumatoid arthritis, and selected advanced solid tumors. Key upstream inputs include engineered expression cell lines, cell culture media, feeds, single-use bioreactor consumables, chromatography resins, ultrafiltration membranes, buffers, sterile filling components, vials or prefilled syringes, stoppers, labels, and cold-chain packaging materials. Major downstream customers include hospitals, specialty treatment centers, oncology departments, hematology departments, rheumatology and immunology departments, pharmaceutical distributors, and public or commercial reimbursement systems. The 2025 global nominal production capacity is estimated at approximately 1.25 million units, actual sales volume at about 728,000 units, average ex-factory price at around USD 690 per unit, and industry gross margin at approximately 68%?82%.
The single-domain antibody drug market is currently in an early commercialization phase, with clear technological advantages but a limited number of marketed products. Existing drugs mainly target rare diseases, rheumatology, and oncology, showing a small-product, high-margin, and highly differentiated market profile. Differences in indications, administration methods, and patient populations create a dispersed yet finely segmented market structure. As indications expand and more candidate drugs gain approval, the market is expected to gradually grow, although near-term expansion remains centered on currently marketed products and is constrained by regulatory approval and hospital access timelines. The global competitive landscape is highly concentrated, with major manufacturers holding technological barriers and patent protections that confer first-mover advantages. Sanofi, Alphamab Oncology, and Taisho Pharmaceutical occupy leading positions in hematology, oncology immunotherapy, and rheumatology, respectively. New entrants face long R&D timelines, clinical validation requirements, and regulatory hurdles, limiting their ability to capture market share in the short term. Competition focuses on product differentiation, clinical application expansion, and production and supply capabilities, with the commercial model revolving around a small number of high-value patients. Future market growth will be driven by indication expansion of marketed products, regional market access, improvements in reimbursement systems, and potential new drug approvals. The structural characteristics of single-domain antibodies provide advantages in subcutaneous administration, tissue penetration, and multispecific design, potentially increasing penetration in rare diseases and specialized oncology immunotherapy. Technological integration, including AI-assisted discovery, high-throughput screening, and optimization platforms, is expected to improve candidate selection efficiency and developability, supporting market expansion. Key barriers remain the limited number of marketed products, narrow indications, long clinical development cycles, strict regulatory requirements, and small patient populations. Some drugs are derived from non-human structures and require humanization and immunogenicity validation. Although single-domain antibodies offer high technological barriers and innovation value, near-term market expansion is limited, and revenue growth depends on market penetration of existing products, indication expansion, and execution capabilities. Overall, market growth is steady but concentrated in a few core products and manufacturers.
This report studies the global Single Domain Antibody(sdAbs) Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Single Domain Antibody(sdAbs) Drugs and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Single Domain Antibody(sdAbs) Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Single Domain Antibody(sdAbs) Drugs total production and demand, 2021-2032, (K Units)
Global Single Domain Antibody(sdAbs) Drugs total production value, 2021-2032, (USD Million)
Global Single Domain Antibody(sdAbs) Drugs production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Single Domain Antibody(sdAbs) Drugs consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Single Domain Antibody(sdAbs) Drugs domestic production, consumption, key domestic manufacturers and share
Global Single Domain Antibody(sdAbs) Drugs production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Single Domain Antibody(sdAbs) Drugs production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Single Domain Antibody(sdAbs) Drugs production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Single Domain Antibody(sdAbs) Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Taisho Pharmaceutical, Alphamab Oncology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Single Domain Antibody(sdAbs) Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Single Domain Antibody(sdAbs) Drugs Market, By Region:
1. How big is the global Single Domain Antibody(sdAbs) Drugs market?
2. What is the demand of the global Single Domain Antibody(sdAbs) Drugs market?
3. What is the year over year growth of the global Single Domain Antibody(sdAbs) Drugs market?
4. What is the production and production value of the global Single Domain Antibody(sdAbs) Drugs market?
5. Who are the key producers in the global Single Domain Antibody(sdAbs) Drugs market?
6. What are the growth factors driving the market demand?
Single Domain Antibody Drugs refer to approved and commercially marketed therapeutic drugs whose active molecules are based on single-domain antibody structures. The currently marketed products mainly include Sanofi's Cablivi, Taisho Pharmaceutical's Nanozora, and Envafolimab manufactured by Alphamab Oncology, covering indications such as acquired thrombotic thrombocytopenic purpura, rheumatoid arthritis, and selected advanced solid tumors. Key upstream inputs include engineered expression cell lines, cell culture media, feeds, single-use bioreactor consumables, chromatography resins, ultrafiltration membranes, buffers, sterile filling components, vials or prefilled syringes, stoppers, labels, and cold-chain packaging materials. Major downstream customers include hospitals, specialty treatment centers, oncology departments, hematology departments, rheumatology and immunology departments, pharmaceutical distributors, and public or commercial reimbursement systems. The 2025 global nominal production capacity is estimated at approximately 1.25 million units, actual sales volume at about 728,000 units, average ex-factory price at around USD 690 per unit, and industry gross margin at approximately 68%?82%.
The single-domain antibody drug market is currently in an early commercialization phase, with clear technological advantages but a limited number of marketed products. Existing drugs mainly target rare diseases, rheumatology, and oncology, showing a small-product, high-margin, and highly differentiated market profile. Differences in indications, administration methods, and patient populations create a dispersed yet finely segmented market structure. As indications expand and more candidate drugs gain approval, the market is expected to gradually grow, although near-term expansion remains centered on currently marketed products and is constrained by regulatory approval and hospital access timelines. The global competitive landscape is highly concentrated, with major manufacturers holding technological barriers and patent protections that confer first-mover advantages. Sanofi, Alphamab Oncology, and Taisho Pharmaceutical occupy leading positions in hematology, oncology immunotherapy, and rheumatology, respectively. New entrants face long R&D timelines, clinical validation requirements, and regulatory hurdles, limiting their ability to capture market share in the short term. Competition focuses on product differentiation, clinical application expansion, and production and supply capabilities, with the commercial model revolving around a small number of high-value patients. Future market growth will be driven by indication expansion of marketed products, regional market access, improvements in reimbursement systems, and potential new drug approvals. The structural characteristics of single-domain antibodies provide advantages in subcutaneous administration, tissue penetration, and multispecific design, potentially increasing penetration in rare diseases and specialized oncology immunotherapy. Technological integration, including AI-assisted discovery, high-throughput screening, and optimization platforms, is expected to improve candidate selection efficiency and developability, supporting market expansion. Key barriers remain the limited number of marketed products, narrow indications, long clinical development cycles, strict regulatory requirements, and small patient populations. Some drugs are derived from non-human structures and require humanization and immunogenicity validation. Although single-domain antibodies offer high technological barriers and innovation value, near-term market expansion is limited, and revenue growth depends on market penetration of existing products, indication expansion, and execution capabilities. Overall, market growth is steady but concentrated in a few core products and manufacturers.
This report studies the global Single Domain Antibody(sdAbs) Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Single Domain Antibody(sdAbs) Drugs and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Single Domain Antibody(sdAbs) Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Single Domain Antibody(sdAbs) Drugs total production and demand, 2021-2032, (K Units)
Global Single Domain Antibody(sdAbs) Drugs total production value, 2021-2032, (USD Million)
Global Single Domain Antibody(sdAbs) Drugs production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Single Domain Antibody(sdAbs) Drugs consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Single Domain Antibody(sdAbs) Drugs domestic production, consumption, key domestic manufacturers and share
Global Single Domain Antibody(sdAbs) Drugs production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Single Domain Antibody(sdAbs) Drugs production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Single Domain Antibody(sdAbs) Drugs production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Single Domain Antibody(sdAbs) Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Taisho Pharmaceutical, Alphamab Oncology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Single Domain Antibody(sdAbs) Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Single Domain Antibody(sdAbs) Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Cablivi
- Nanozora
- Envafolimab
- Subcutaneous Injection
- Intravenous Injection
- Other
- Online Sales
- Offline Sales
- Hospital
- Clinic
- Other
- Sanofi
- Taisho Pharmaceutical
- Alphamab Oncology
1. How big is the global Single Domain Antibody(sdAbs) Drugs market?
2. What is the demand of the global Single Domain Antibody(sdAbs) Drugs market?
3. What is the year over year growth of the global Single Domain Antibody(sdAbs) Drugs market?
4. What is the production and production value of the global Single Domain Antibody(sdAbs) Drugs market?
5. Who are the key producers in the global Single Domain Antibody(sdAbs) Drugs market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Single Domain Antibody(sdAbs) Drugs Introduction
1.2 World Single Domain Antibody(sdAbs) Drugs Supply & Forecast
1.2.1 World Single Domain Antibody(sdAbs) Drugs Production Value (2021 & 2025 & 2032)
1.2.2 World Single Domain Antibody(sdAbs) Drugs Production (2021-2032)
1.2.3 World Single Domain Antibody(sdAbs) Drugs Pricing Trends (2021-2032)
1.3 World Single Domain Antibody(sdAbs) Drugs Production by Region (Based on Production Site)
1.3.1 World Single Domain Antibody(sdAbs) Drugs Production Value by Region (2021-2032)
1.3.2 World Single Domain Antibody(sdAbs) Drugs Production by Region (2021-2032)
1.3.3 World Single Domain Antibody(sdAbs) Drugs Average Price by Region (2021-2032)
1.3.4 North America Single Domain Antibody(sdAbs) Drugs Production (2021-2032)
1.3.5 Europe Single Domain Antibody(sdAbs) Drugs Production (2021-2032)
1.3.6 China Single Domain Antibody(sdAbs) Drugs Production (2021-2032)
1.3.7 Japan Single Domain Antibody(sdAbs) Drugs Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Single Domain Antibody(sdAbs) Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Single Domain Antibody(sdAbs) Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World Single Domain Antibody(sdAbs) Drugs Demand (2021-2032)
2.2 World Single Domain Antibody(sdAbs) Drugs Consumption by Region
2.2.1 World Single Domain Antibody(sdAbs) Drugs Consumption by Region (2021-2026)
2.2.2 World Single Domain Antibody(sdAbs) Drugs Consumption Forecast by Region (2027-2032)
2.3 United States Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032)
2.4 China Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032)
2.5 Europe Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032)
2.6 Japan Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032)
2.7 South Korea Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032)
2.8 ASEAN Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032)
2.9 India Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Single Domain Antibody(sdAbs) Drugs Production Value by Manufacturer (2021-2026)
3.2 World Single Domain Antibody(sdAbs) Drugs Production by Manufacturer (2021-2026)
3.3 World Single Domain Antibody(sdAbs) Drugs Average Price by Manufacturer (2021-2026)
3.4 Single Domain Antibody(sdAbs) Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Single Domain Antibody(sdAbs) Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Single Domain Antibody(sdAbs) Drugs in 2025
3.5.3 Global Concentration Ratios (CR8) for Single Domain Antibody(sdAbs) Drugs in 2025
3.6 Single Domain Antibody(sdAbs) Drugs Market: Overall Company Footprint Analysis
3.6.1 Single Domain Antibody(sdAbs) Drugs Market: Region Footprint
3.6.2 Single Domain Antibody(sdAbs) Drugs Market: Company Product Type Footprint
3.6.3 Single Domain Antibody(sdAbs) Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Single Domain Antibody(sdAbs) Drugs Production Value Comparison
4.1.1 United States VS China: Single Domain Antibody(sdAbs) Drugs Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Single Domain Antibody(sdAbs) Drugs Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Single Domain Antibody(sdAbs) Drugs Production Comparison
4.2.1 United States VS China: Single Domain Antibody(sdAbs) Drugs Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Single Domain Antibody(sdAbs) Drugs Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Single Domain Antibody(sdAbs) Drugs Consumption Comparison
4.3.1 United States VS China: Single Domain Antibody(sdAbs) Drugs Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Single Domain Antibody(sdAbs) Drugs Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Single Domain Antibody(sdAbs) Drugs Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Single Domain Antibody(sdAbs) Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Value (2021-2026)
4.4.3 United States Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production (2021-2026)
4.5 China Based Single Domain Antibody(sdAbs) Drugs Manufacturers and Market Share
4.5.1 China Based Single Domain Antibody(sdAbs) Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Value (2021-2026)
4.5.3 China Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production (2021-2026)
4.6 Rest of World Based Single Domain Antibody(sdAbs) Drugs Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Single Domain Antibody(sdAbs) Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Single Domain Antibody(sdAbs) Drugs Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Cablivi
5.2.2 Nanozora
5.2.3 Envafolimab
5.3 Market Segment by Type
5.3.1 World Single Domain Antibody(sdAbs) Drugs Production by Type (2021-2032)
5.3.2 World Single Domain Antibody(sdAbs) Drugs Production Value by Type (2021-2032)
5.3.3 World Single Domain Antibody(sdAbs) Drugs Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.1 World Single Domain Antibody(sdAbs) Drugs Market Size Overview by Administration Route: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Administration Route
6.2.1 Subcutaneous Injection
6.2.2 Intravenous Injection
6.2.3 Other
6.3 Market Segment by Administration Route
6.3.1 World Single Domain Antibody(sdAbs) Drugs Production by Administration Route (2021-2032)
6.3.2 World Single Domain Antibody(sdAbs) Drugs Production Value by Administration Route (2021-2032)
6.3.3 World Single Domain Antibody(sdAbs) Drugs Average Price by Administration Route (2021-2032)
7 MARKET ANALYSIS BY SALES CHANNELS
7.1 World Single Domain Antibody(sdAbs) Drugs Market Size Overview by Sales Channels: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sales Channels
7.2.1 Online Sales
7.2.2 Offline Sales
7.3 Market Segment by Sales Channels
7.3.1 World Single Domain Antibody(sdAbs) Drugs Production by Sales Channels (2021-2032)
7.3.2 World Single Domain Antibody(sdAbs) Drugs Production Value by Sales Channels (2021-2032)
7.3.3 World Single Domain Antibody(sdAbs) Drugs Average Price by Sales Channels (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Single Domain Antibody(sdAbs) Drugs Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Clinic
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World Single Domain Antibody(sdAbs) Drugs Production by Application (2021-2032)
8.3.2 World Single Domain Antibody(sdAbs) Drugs Production Value by Application (2021-2032)
8.3.3 World Single Domain Antibody(sdAbs) Drugs Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Sanofi
9.1.1 Sanofi Details
9.1.2 Sanofi Major Business
9.1.3 Sanofi Single Domain Antibody(sdAbs) Drugs Product and Services
9.1.4 Sanofi Single Domain Antibody(sdAbs) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Sanofi Recent Developments/Updates
9.1.6 Sanofi Competitive Strengths & Weaknesses
9.2 Taisho Pharmaceutical
9.2.1 Taisho Pharmaceutical Details
9.2.2 Taisho Pharmaceutical Major Business
9.2.3 Taisho Pharmaceutical Single Domain Antibody(sdAbs) Drugs Product and Services
9.2.4 Taisho Pharmaceutical Single Domain Antibody(sdAbs) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Taisho Pharmaceutical Recent Developments/Updates
9.2.6 Taisho Pharmaceutical Competitive Strengths & Weaknesses
9.3 Alphamab Oncology
9.3.1 Alphamab Oncology Details
9.3.2 Alphamab Oncology Major Business
9.3.3 Alphamab Oncology Single Domain Antibody(sdAbs) Drugs Product and Services
9.3.4 Alphamab Oncology Single Domain Antibody(sdAbs) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Alphamab Oncology Recent Developments/Updates
9.3.6 Alphamab Oncology Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Single Domain Antibody(sdAbs) Drugs Industry Chain
10.2 Single Domain Antibody(sdAbs) Drugs Upstream Analysis
10.2.1 Single Domain Antibody(sdAbs) Drugs Core Raw Materials
10.2.2 Main Manufacturers of Single Domain Antibody(sdAbs) Drugs Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Single Domain Antibody(sdAbs) Drugs Production Mode
10.6 Single Domain Antibody(sdAbs) Drugs Procurement Model
10.7 Single Domain Antibody(sdAbs) Drugs Industry Sales Model and Sales Channels
10.7.1 Single Domain Antibody(sdAbs) Drugs Sales Model
10.7.2 Single Domain Antibody(sdAbs) Drugs Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Single Domain Antibody(sdAbs) Drugs Introduction
1.2 World Single Domain Antibody(sdAbs) Drugs Supply & Forecast
1.2.1 World Single Domain Antibody(sdAbs) Drugs Production Value (2021 & 2025 & 2032)
1.2.2 World Single Domain Antibody(sdAbs) Drugs Production (2021-2032)
1.2.3 World Single Domain Antibody(sdAbs) Drugs Pricing Trends (2021-2032)
1.3 World Single Domain Antibody(sdAbs) Drugs Production by Region (Based on Production Site)
1.3.1 World Single Domain Antibody(sdAbs) Drugs Production Value by Region (2021-2032)
1.3.2 World Single Domain Antibody(sdAbs) Drugs Production by Region (2021-2032)
1.3.3 World Single Domain Antibody(sdAbs) Drugs Average Price by Region (2021-2032)
1.3.4 North America Single Domain Antibody(sdAbs) Drugs Production (2021-2032)
1.3.5 Europe Single Domain Antibody(sdAbs) Drugs Production (2021-2032)
1.3.6 China Single Domain Antibody(sdAbs) Drugs Production (2021-2032)
1.3.7 Japan Single Domain Antibody(sdAbs) Drugs Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Single Domain Antibody(sdAbs) Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Single Domain Antibody(sdAbs) Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World Single Domain Antibody(sdAbs) Drugs Demand (2021-2032)
2.2 World Single Domain Antibody(sdAbs) Drugs Consumption by Region
2.2.1 World Single Domain Antibody(sdAbs) Drugs Consumption by Region (2021-2026)
2.2.2 World Single Domain Antibody(sdAbs) Drugs Consumption Forecast by Region (2027-2032)
2.3 United States Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032)
2.4 China Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032)
2.5 Europe Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032)
2.6 Japan Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032)
2.7 South Korea Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032)
2.8 ASEAN Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032)
2.9 India Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Single Domain Antibody(sdAbs) Drugs Production Value by Manufacturer (2021-2026)
3.2 World Single Domain Antibody(sdAbs) Drugs Production by Manufacturer (2021-2026)
3.3 World Single Domain Antibody(sdAbs) Drugs Average Price by Manufacturer (2021-2026)
3.4 Single Domain Antibody(sdAbs) Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Single Domain Antibody(sdAbs) Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Single Domain Antibody(sdAbs) Drugs in 2025
3.5.3 Global Concentration Ratios (CR8) for Single Domain Antibody(sdAbs) Drugs in 2025
3.6 Single Domain Antibody(sdAbs) Drugs Market: Overall Company Footprint Analysis
3.6.1 Single Domain Antibody(sdAbs) Drugs Market: Region Footprint
3.6.2 Single Domain Antibody(sdAbs) Drugs Market: Company Product Type Footprint
3.6.3 Single Domain Antibody(sdAbs) Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Single Domain Antibody(sdAbs) Drugs Production Value Comparison
4.1.1 United States VS China: Single Domain Antibody(sdAbs) Drugs Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Single Domain Antibody(sdAbs) Drugs Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Single Domain Antibody(sdAbs) Drugs Production Comparison
4.2.1 United States VS China: Single Domain Antibody(sdAbs) Drugs Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Single Domain Antibody(sdAbs) Drugs Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Single Domain Antibody(sdAbs) Drugs Consumption Comparison
4.3.1 United States VS China: Single Domain Antibody(sdAbs) Drugs Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Single Domain Antibody(sdAbs) Drugs Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Single Domain Antibody(sdAbs) Drugs Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Single Domain Antibody(sdAbs) Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Value (2021-2026)
4.4.3 United States Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production (2021-2026)
4.5 China Based Single Domain Antibody(sdAbs) Drugs Manufacturers and Market Share
4.5.1 China Based Single Domain Antibody(sdAbs) Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Value (2021-2026)
4.5.3 China Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production (2021-2026)
4.6 Rest of World Based Single Domain Antibody(sdAbs) Drugs Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Single Domain Antibody(sdAbs) Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Single Domain Antibody(sdAbs) Drugs Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Cablivi
5.2.2 Nanozora
5.2.3 Envafolimab
5.3 Market Segment by Type
5.3.1 World Single Domain Antibody(sdAbs) Drugs Production by Type (2021-2032)
5.3.2 World Single Domain Antibody(sdAbs) Drugs Production Value by Type (2021-2032)
5.3.3 World Single Domain Antibody(sdAbs) Drugs Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.1 World Single Domain Antibody(sdAbs) Drugs Market Size Overview by Administration Route: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Administration Route
6.2.1 Subcutaneous Injection
6.2.2 Intravenous Injection
6.2.3 Other
6.3 Market Segment by Administration Route
6.3.1 World Single Domain Antibody(sdAbs) Drugs Production by Administration Route (2021-2032)
6.3.2 World Single Domain Antibody(sdAbs) Drugs Production Value by Administration Route (2021-2032)
6.3.3 World Single Domain Antibody(sdAbs) Drugs Average Price by Administration Route (2021-2032)
7 MARKET ANALYSIS BY SALES CHANNELS
7.1 World Single Domain Antibody(sdAbs) Drugs Market Size Overview by Sales Channels: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sales Channels
7.2.1 Online Sales
7.2.2 Offline Sales
7.3 Market Segment by Sales Channels
7.3.1 World Single Domain Antibody(sdAbs) Drugs Production by Sales Channels (2021-2032)
7.3.2 World Single Domain Antibody(sdAbs) Drugs Production Value by Sales Channels (2021-2032)
7.3.3 World Single Domain Antibody(sdAbs) Drugs Average Price by Sales Channels (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Single Domain Antibody(sdAbs) Drugs Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Clinic
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World Single Domain Antibody(sdAbs) Drugs Production by Application (2021-2032)
8.3.2 World Single Domain Antibody(sdAbs) Drugs Production Value by Application (2021-2032)
8.3.3 World Single Domain Antibody(sdAbs) Drugs Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Sanofi
9.1.1 Sanofi Details
9.1.2 Sanofi Major Business
9.1.3 Sanofi Single Domain Antibody(sdAbs) Drugs Product and Services
9.1.4 Sanofi Single Domain Antibody(sdAbs) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Sanofi Recent Developments/Updates
9.1.6 Sanofi Competitive Strengths & Weaknesses
9.2 Taisho Pharmaceutical
9.2.1 Taisho Pharmaceutical Details
9.2.2 Taisho Pharmaceutical Major Business
9.2.3 Taisho Pharmaceutical Single Domain Antibody(sdAbs) Drugs Product and Services
9.2.4 Taisho Pharmaceutical Single Domain Antibody(sdAbs) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Taisho Pharmaceutical Recent Developments/Updates
9.2.6 Taisho Pharmaceutical Competitive Strengths & Weaknesses
9.3 Alphamab Oncology
9.3.1 Alphamab Oncology Details
9.3.2 Alphamab Oncology Major Business
9.3.3 Alphamab Oncology Single Domain Antibody(sdAbs) Drugs Product and Services
9.3.4 Alphamab Oncology Single Domain Antibody(sdAbs) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Alphamab Oncology Recent Developments/Updates
9.3.6 Alphamab Oncology Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Single Domain Antibody(sdAbs) Drugs Industry Chain
10.2 Single Domain Antibody(sdAbs) Drugs Upstream Analysis
10.2.1 Single Domain Antibody(sdAbs) Drugs Core Raw Materials
10.2.2 Main Manufacturers of Single Domain Antibody(sdAbs) Drugs Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Single Domain Antibody(sdAbs) Drugs Production Mode
10.6 Single Domain Antibody(sdAbs) Drugs Procurement Model
10.7 Single Domain Antibody(sdAbs) Drugs Industry Sales Model and Sales Channels
10.7.1 Single Domain Antibody(sdAbs) Drugs Sales Model
10.7.2 Single Domain Antibody(sdAbs) Drugs Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Single Domain Antibody(sdAbs) Drugs Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Single Domain Antibody(sdAbs) Drugs Production Value by Region (2021-2026) & (USD Million)
Table 3. World Single Domain Antibody(sdAbs) Drugs Production Value by Region (2027-2032) & (USD Million)
Table 4. World Single Domain Antibody(sdAbs) Drugs Production Value Market Share by Region (2021-2026)
Table 5. World Single Domain Antibody(sdAbs) Drugs Production Value Market Share by Region (2027-2032)
Table 6. World Single Domain Antibody(sdAbs) Drugs Production by Region (2021-2026) & (K Units)
Table 7. World Single Domain Antibody(sdAbs) Drugs Production by Region (2027-2032) & (K Units)
Table 8. World Single Domain Antibody(sdAbs) Drugs Production Market Share by Region (2021-2026)
Table 9. World Single Domain Antibody(sdAbs) Drugs Production Market Share by Region (2027-2032)
Table 10. World Single Domain Antibody(sdAbs) Drugs Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Single Domain Antibody(sdAbs) Drugs Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Single Domain Antibody(sdAbs) Drugs Major Market Trends
Table 13. World Single Domain Antibody(sdAbs) Drugs Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Single Domain Antibody(sdAbs) Drugs Consumption by Region (2021-2026) & (K Units)
Table 15. World Single Domain Antibody(sdAbs) Drugs Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Single Domain Antibody(sdAbs) Drugs Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Single Domain Antibody(sdAbs) Drugs Producers in 2025
Table 18. World Single Domain Antibody(sdAbs) Drugs Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Single Domain Antibody(sdAbs) Drugs Producers in 2025
Table 20. World Single Domain Antibody(sdAbs) Drugs Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Single Domain Antibody(sdAbs) Drugs Company Evaluation Quadrant
Table 22. World Single Domain Antibody(sdAbs) Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Single Domain Antibody(sdAbs) Drugs Production Site of Key Manufacturer
Table 24. Single Domain Antibody(sdAbs) Drugs Market: Company Product Type Footprint
Table 25. Single Domain Antibody(sdAbs) Drugs Market: Company Product Application Footprint
Table 26. Single Domain Antibody(sdAbs) Drugs Competitive Factors
Table 27. Single Domain Antibody(sdAbs) Drugs New Entrant and Capacity Expansion Plans
Table 28. Single Domain Antibody(sdAbs) Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Single Domain Antibody(sdAbs) Drugs Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Single Domain Antibody(sdAbs) Drugs Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Single Domain Antibody(sdAbs) Drugs Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Single Domain Antibody(sdAbs) Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Market Share (2021-2026)
Table 37. China Based Single Domain Antibody(sdAbs) Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Market Share (2021-2026)
Table 42. Rest of World Based Single Domain Antibody(sdAbs) Drugs Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Market Share (2021-2026)
Table 47. World Single Domain Antibody(sdAbs) Drugs Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Single Domain Antibody(sdAbs) Drugs Production by Type (2021-2026) & (K Units)
Table 49. World Single Domain Antibody(sdAbs) Drugs Production by Type (2027-2032) & (K Units)
Table 50. World Single Domain Antibody(sdAbs) Drugs Production Value by Type (2021-2026) & (USD Million)
Table 51. World Single Domain Antibody(sdAbs) Drugs Production Value by Type (2027-2032) & (USD Million)
Table 52. World Single Domain Antibody(sdAbs) Drugs Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Single Domain Antibody(sdAbs) Drugs Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Single Domain Antibody(sdAbs) Drugs Production Value by Administration Route, (USD Million), 2021 & 2025 & 2032
Table 55. World Single Domain Antibody(sdAbs) Drugs Production by Administration Route (2021-2026) & (K Units)
Table 56. World Single Domain Antibody(sdAbs) Drugs Production by Administration Route (2027-2032) & (K Units)
Table 57. World Single Domain Antibody(sdAbs) Drugs Production Value by Administration Route (2021-2026) & (USD Million)
Table 58. World Single Domain Antibody(sdAbs) Drugs Production Value by Administration Route (2027-2032) & (USD Million)
Table 59. World Single Domain Antibody(sdAbs) Drugs Average Price by Administration Route (2021-2026) & (US$/Unit)
Table 60. World Single Domain Antibody(sdAbs) Drugs Average Price by Administration Route (2027-2032) & (US$/Unit)
Table 61. World Single Domain Antibody(sdAbs) Drugs Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 62. World Single Domain Antibody(sdAbs) Drugs Production by Sales Channels (2021-2026) & (K Units)
Table 63. World Single Domain Antibody(sdAbs) Drugs Production by Sales Channels (2027-2032) & (K Units)
Table 64. World Single Domain Antibody(sdAbs) Drugs Production Value by Sales Channels (2021-2026) & (USD Million)
Table 65. World Single Domain Antibody(sdAbs) Drugs Production Value by Sales Channels (2027-2032) & (USD Million)
Table 66. World Single Domain Antibody(sdAbs) Drugs Average Price by Sales Channels (2021-2026) & (US$/Unit)
Table 67. World Single Domain Antibody(sdAbs) Drugs Average Price by Sales Channels (2027-2032) & (US$/Unit)
Table 68. World Single Domain Antibody(sdAbs) Drugs Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Single Domain Antibody(sdAbs) Drugs Production by Application (2021-2026) & (K Units)
Table 70. World Single Domain Antibody(sdAbs) Drugs Production by Application (2027-2032) & (K Units)
Table 71. World Single Domain Antibody(sdAbs) Drugs Production Value by Application (2021-2026) & (USD Million)
Table 72. World Single Domain Antibody(sdAbs) Drugs Production Value by Application (2027-2032) & (USD Million)
Table 73. World Single Domain Antibody(sdAbs) Drugs Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Single Domain Antibody(sdAbs) Drugs Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Sanofi Basic Information, Manufacturing Base and Competitors
Table 76. Sanofi Major Business
Table 77. Sanofi Single Domain Antibody(sdAbs) Drugs Product and Services
Table 78. Sanofi Single Domain Antibody(sdAbs) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Sanofi Recent Developments/Updates
Table 80. Sanofi Competitive Strengths & Weaknesses
Table 81. Taisho Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 82. Taisho Pharmaceutical Major Business
Table 83. Taisho Pharmaceutical Single Domain Antibody(sdAbs) Drugs Product and Services
Table 84. Taisho Pharmaceutical Single Domain Antibody(sdAbs) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Taisho Pharmaceutical Recent Developments/Updates
Table 86. Taisho Pharmaceutical Competitive Strengths & Weaknesses
Table 87. Alphamab Oncology Basic Information, Manufacturing Base and Competitors
Table 88. Alphamab Oncology Major Business
Table 89. Alphamab Oncology Single Domain Antibody(sdAbs) Drugs Product and Services
Table 90. Alphamab Oncology Single Domain Antibody(sdAbs) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Alphamab Oncology Recent Developments/Updates
Table 92. Alphamab Oncology Competitive Strengths & Weaknesses
Table 93. Global Key Players of Single Domain Antibody(sdAbs) Drugs Upstream (Raw Materials)
Table 94. Global Single Domain Antibody(sdAbs) Drugs Typical Customers
Table 95. Single Domain Antibody(sdAbs) Drugs Typical Distributors
Table 1. World Single Domain Antibody(sdAbs) Drugs Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Single Domain Antibody(sdAbs) Drugs Production Value by Region (2021-2026) & (USD Million)
Table 3. World Single Domain Antibody(sdAbs) Drugs Production Value by Region (2027-2032) & (USD Million)
Table 4. World Single Domain Antibody(sdAbs) Drugs Production Value Market Share by Region (2021-2026)
Table 5. World Single Domain Antibody(sdAbs) Drugs Production Value Market Share by Region (2027-2032)
Table 6. World Single Domain Antibody(sdAbs) Drugs Production by Region (2021-2026) & (K Units)
Table 7. World Single Domain Antibody(sdAbs) Drugs Production by Region (2027-2032) & (K Units)
Table 8. World Single Domain Antibody(sdAbs) Drugs Production Market Share by Region (2021-2026)
Table 9. World Single Domain Antibody(sdAbs) Drugs Production Market Share by Region (2027-2032)
Table 10. World Single Domain Antibody(sdAbs) Drugs Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Single Domain Antibody(sdAbs) Drugs Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Single Domain Antibody(sdAbs) Drugs Major Market Trends
Table 13. World Single Domain Antibody(sdAbs) Drugs Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Single Domain Antibody(sdAbs) Drugs Consumption by Region (2021-2026) & (K Units)
Table 15. World Single Domain Antibody(sdAbs) Drugs Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Single Domain Antibody(sdAbs) Drugs Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Single Domain Antibody(sdAbs) Drugs Producers in 2025
Table 18. World Single Domain Antibody(sdAbs) Drugs Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Single Domain Antibody(sdAbs) Drugs Producers in 2025
Table 20. World Single Domain Antibody(sdAbs) Drugs Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Single Domain Antibody(sdAbs) Drugs Company Evaluation Quadrant
Table 22. World Single Domain Antibody(sdAbs) Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Single Domain Antibody(sdAbs) Drugs Production Site of Key Manufacturer
Table 24. Single Domain Antibody(sdAbs) Drugs Market: Company Product Type Footprint
Table 25. Single Domain Antibody(sdAbs) Drugs Market: Company Product Application Footprint
Table 26. Single Domain Antibody(sdAbs) Drugs Competitive Factors
Table 27. Single Domain Antibody(sdAbs) Drugs New Entrant and Capacity Expansion Plans
Table 28. Single Domain Antibody(sdAbs) Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Single Domain Antibody(sdAbs) Drugs Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Single Domain Antibody(sdAbs) Drugs Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Single Domain Antibody(sdAbs) Drugs Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Single Domain Antibody(sdAbs) Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Market Share (2021-2026)
Table 37. China Based Single Domain Antibody(sdAbs) Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Market Share (2021-2026)
Table 42. Rest of World Based Single Domain Antibody(sdAbs) Drugs Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Market Share (2021-2026)
Table 47. World Single Domain Antibody(sdAbs) Drugs Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Single Domain Antibody(sdAbs) Drugs Production by Type (2021-2026) & (K Units)
Table 49. World Single Domain Antibody(sdAbs) Drugs Production by Type (2027-2032) & (K Units)
Table 50. World Single Domain Antibody(sdAbs) Drugs Production Value by Type (2021-2026) & (USD Million)
Table 51. World Single Domain Antibody(sdAbs) Drugs Production Value by Type (2027-2032) & (USD Million)
Table 52. World Single Domain Antibody(sdAbs) Drugs Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Single Domain Antibody(sdAbs) Drugs Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Single Domain Antibody(sdAbs) Drugs Production Value by Administration Route, (USD Million), 2021 & 2025 & 2032
Table 55. World Single Domain Antibody(sdAbs) Drugs Production by Administration Route (2021-2026) & (K Units)
Table 56. World Single Domain Antibody(sdAbs) Drugs Production by Administration Route (2027-2032) & (K Units)
Table 57. World Single Domain Antibody(sdAbs) Drugs Production Value by Administration Route (2021-2026) & (USD Million)
Table 58. World Single Domain Antibody(sdAbs) Drugs Production Value by Administration Route (2027-2032) & (USD Million)
Table 59. World Single Domain Antibody(sdAbs) Drugs Average Price by Administration Route (2021-2026) & (US$/Unit)
Table 60. World Single Domain Antibody(sdAbs) Drugs Average Price by Administration Route (2027-2032) & (US$/Unit)
Table 61. World Single Domain Antibody(sdAbs) Drugs Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 62. World Single Domain Antibody(sdAbs) Drugs Production by Sales Channels (2021-2026) & (K Units)
Table 63. World Single Domain Antibody(sdAbs) Drugs Production by Sales Channels (2027-2032) & (K Units)
Table 64. World Single Domain Antibody(sdAbs) Drugs Production Value by Sales Channels (2021-2026) & (USD Million)
Table 65. World Single Domain Antibody(sdAbs) Drugs Production Value by Sales Channels (2027-2032) & (USD Million)
Table 66. World Single Domain Antibody(sdAbs) Drugs Average Price by Sales Channels (2021-2026) & (US$/Unit)
Table 67. World Single Domain Antibody(sdAbs) Drugs Average Price by Sales Channels (2027-2032) & (US$/Unit)
Table 68. World Single Domain Antibody(sdAbs) Drugs Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Single Domain Antibody(sdAbs) Drugs Production by Application (2021-2026) & (K Units)
Table 70. World Single Domain Antibody(sdAbs) Drugs Production by Application (2027-2032) & (K Units)
Table 71. World Single Domain Antibody(sdAbs) Drugs Production Value by Application (2021-2026) & (USD Million)
Table 72. World Single Domain Antibody(sdAbs) Drugs Production Value by Application (2027-2032) & (USD Million)
Table 73. World Single Domain Antibody(sdAbs) Drugs Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Single Domain Antibody(sdAbs) Drugs Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Sanofi Basic Information, Manufacturing Base and Competitors
Table 76. Sanofi Major Business
Table 77. Sanofi Single Domain Antibody(sdAbs) Drugs Product and Services
Table 78. Sanofi Single Domain Antibody(sdAbs) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Sanofi Recent Developments/Updates
Table 80. Sanofi Competitive Strengths & Weaknesses
Table 81. Taisho Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 82. Taisho Pharmaceutical Major Business
Table 83. Taisho Pharmaceutical Single Domain Antibody(sdAbs) Drugs Product and Services
Table 84. Taisho Pharmaceutical Single Domain Antibody(sdAbs) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Taisho Pharmaceutical Recent Developments/Updates
Table 86. Taisho Pharmaceutical Competitive Strengths & Weaknesses
Table 87. Alphamab Oncology Basic Information, Manufacturing Base and Competitors
Table 88. Alphamab Oncology Major Business
Table 89. Alphamab Oncology Single Domain Antibody(sdAbs) Drugs Product and Services
Table 90. Alphamab Oncology Single Domain Antibody(sdAbs) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Alphamab Oncology Recent Developments/Updates
Table 92. Alphamab Oncology Competitive Strengths & Weaknesses
Table 93. Global Key Players of Single Domain Antibody(sdAbs) Drugs Upstream (Raw Materials)
Table 94. Global Single Domain Antibody(sdAbs) Drugs Typical Customers
Table 95. Single Domain Antibody(sdAbs) Drugs Typical Distributors
LIST OF FIGURES
Figure 1. Single Domain Antibody(sdAbs) Drugs Picture
Figure 2. World Single Domain Antibody(sdAbs) Drugs Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Single Domain Antibody(sdAbs) Drugs Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Single Domain Antibody(sdAbs) Drugs Production (2021-2032) & (K Units)
Figure 5. World Single Domain Antibody(sdAbs) Drugs Average Price (2021-2032) & (US$/Unit)
Figure 6. World Single Domain Antibody(sdAbs) Drugs Production Value Market Share by Region (2021-2032)
Figure 7. World Single Domain Antibody(sdAbs) Drugs Production Market Share by Region (2021-2032)
Figure 8. North America Single Domain Antibody(sdAbs) Drugs Production (2021-2032) & (K Units)
Figure 9. Europe Single Domain Antibody(sdAbs) Drugs Production (2021-2032) & (K Units)
Figure 10. China Single Domain Antibody(sdAbs) Drugs Production (2021-2032) & (K Units)
Figure 11. Japan Single Domain Antibody(sdAbs) Drugs Production (2021-2032) & (K Units)
Figure 12. Single Domain Antibody(sdAbs) Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032) & (K Units)
Figure 15. World Single Domain Antibody(sdAbs) Drugs Consumption Market Share by Region (2021-2032)
Figure 16. United States Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032) & (K Units)
Figure 17. China Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032) & (K Units)
Figure 18. Europe Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032) & (K Units)
Figure 19. Japan Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032) & (K Units)
Figure 20. South Korea Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032) & (K Units)
Figure 22. India Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Single Domain Antibody(sdAbs) Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Single Domain Antibody(sdAbs) Drugs Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Single Domain Antibody(sdAbs) Drugs Markets in 2025
Figure 26. United States VS China: Single Domain Antibody(sdAbs) Drugs Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Single Domain Antibody(sdAbs) Drugs Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Single Domain Antibody(sdAbs) Drugs Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Market Share 2025
Figure 30. China Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Market Share 2025
Figure 32. World Single Domain Antibody(sdAbs) Drugs Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Single Domain Antibody(sdAbs) Drugs Production Value Market Share by Type in 2025
Figure 34. Cablivi
Figure 35. Nanozora
Figure 36. Envafolimab
Figure 37. World Single Domain Antibody(sdAbs) Drugs Production Market Share by Type (2021-2032)
Figure 38. World Single Domain Antibody(sdAbs) Drugs Production Value Market Share by Type (2021-2032)
Figure 39. World Single Domain Antibody(sdAbs) Drugs Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Single Domain Antibody(sdAbs) Drugs Production Value by Administration Route, (USD Million), 2021 & 2025 & 2032
Figure 41. World Single Domain Antibody(sdAbs) Drugs Production Value Market Share by Administration Route in 2025
Figure 42. Subcutaneous Injection
Figure 43. Intravenous Injection
Figure 44. Other
Figure 45. World Single Domain Antibody(sdAbs) Drugs Production Market Share by Administration Route (2021-2032)
Figure 46. World Single Domain Antibody(sdAbs) Drugs Production Value Market Share by Administration Route (2021-2032)
Figure 47. World Single Domain Antibody(sdAbs) Drugs Average Price by Administration Route (2021-2032) & (US$/Unit)
Figure 48. World Single Domain Antibody(sdAbs) Drugs Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 49. World Single Domain Antibody(sdAbs) Drugs Production Value Market Share by Sales Channels in 2025
Figure 50. Online Sales
Figure 51. Offline Sales
Figure 52. World Single Domain Antibody(sdAbs) Drugs Production Market Share by Sales Channels (2021-2032)
Figure 53. World Single Domain Antibody(sdAbs) Drugs Production Value Market Share by Sales Channels (2021-2032)
Figure 54. World Single Domain Antibody(sdAbs) Drugs Average Price by Sales Channels (2021-2032) & (US$/Unit)
Figure 55. World Single Domain Antibody(sdAbs) Drugs Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Single Domain Antibody(sdAbs) Drugs Production Value Market Share by Application in 2025
Figure 57. Hospital
Figure 58. Clinic
Figure 59. Other
Figure 60. World Single Domain Antibody(sdAbs) Drugs Production Market Share by Application (2021-2032)
Figure 61. World Single Domain Antibody(sdAbs) Drugs Production Value Market Share by Application (2021-2032)
Figure 62. World Single Domain Antibody(sdAbs) Drugs Average Price by Application (2021-2032) & (US$/Unit)
Figure 63. Single Domain Antibody(sdAbs) Drugs Industry Chain
Figure 64. Single Domain Antibody(sdAbs) Drugs Procurement Model
Figure 65. Single Domain Antibody(sdAbs) Drugs Sales Model
Figure 66. Single Domain Antibody(sdAbs) Drugs Sales Channels, Direct Sales, and Distribution
Figure 67. Methodology
Figure 68. Research Process and Data Source
Figure 1. Single Domain Antibody(sdAbs) Drugs Picture
Figure 2. World Single Domain Antibody(sdAbs) Drugs Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Single Domain Antibody(sdAbs) Drugs Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Single Domain Antibody(sdAbs) Drugs Production (2021-2032) & (K Units)
Figure 5. World Single Domain Antibody(sdAbs) Drugs Average Price (2021-2032) & (US$/Unit)
Figure 6. World Single Domain Antibody(sdAbs) Drugs Production Value Market Share by Region (2021-2032)
Figure 7. World Single Domain Antibody(sdAbs) Drugs Production Market Share by Region (2021-2032)
Figure 8. North America Single Domain Antibody(sdAbs) Drugs Production (2021-2032) & (K Units)
Figure 9. Europe Single Domain Antibody(sdAbs) Drugs Production (2021-2032) & (K Units)
Figure 10. China Single Domain Antibody(sdAbs) Drugs Production (2021-2032) & (K Units)
Figure 11. Japan Single Domain Antibody(sdAbs) Drugs Production (2021-2032) & (K Units)
Figure 12. Single Domain Antibody(sdAbs) Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032) & (K Units)
Figure 15. World Single Domain Antibody(sdAbs) Drugs Consumption Market Share by Region (2021-2032)
Figure 16. United States Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032) & (K Units)
Figure 17. China Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032) & (K Units)
Figure 18. Europe Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032) & (K Units)
Figure 19. Japan Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032) & (K Units)
Figure 20. South Korea Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032) & (K Units)
Figure 22. India Single Domain Antibody(sdAbs) Drugs Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Single Domain Antibody(sdAbs) Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Single Domain Antibody(sdAbs) Drugs Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Single Domain Antibody(sdAbs) Drugs Markets in 2025
Figure 26. United States VS China: Single Domain Antibody(sdAbs) Drugs Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Single Domain Antibody(sdAbs) Drugs Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Single Domain Antibody(sdAbs) Drugs Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Market Share 2025
Figure 30. China Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Single Domain Antibody(sdAbs) Drugs Production Market Share 2025
Figure 32. World Single Domain Antibody(sdAbs) Drugs Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Single Domain Antibody(sdAbs) Drugs Production Value Market Share by Type in 2025
Figure 34. Cablivi
Figure 35. Nanozora
Figure 36. Envafolimab
Figure 37. World Single Domain Antibody(sdAbs) Drugs Production Market Share by Type (2021-2032)
Figure 38. World Single Domain Antibody(sdAbs) Drugs Production Value Market Share by Type (2021-2032)
Figure 39. World Single Domain Antibody(sdAbs) Drugs Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Single Domain Antibody(sdAbs) Drugs Production Value by Administration Route, (USD Million), 2021 & 2025 & 2032
Figure 41. World Single Domain Antibody(sdAbs) Drugs Production Value Market Share by Administration Route in 2025
Figure 42. Subcutaneous Injection
Figure 43. Intravenous Injection
Figure 44. Other
Figure 45. World Single Domain Antibody(sdAbs) Drugs Production Market Share by Administration Route (2021-2032)
Figure 46. World Single Domain Antibody(sdAbs) Drugs Production Value Market Share by Administration Route (2021-2032)
Figure 47. World Single Domain Antibody(sdAbs) Drugs Average Price by Administration Route (2021-2032) & (US$/Unit)
Figure 48. World Single Domain Antibody(sdAbs) Drugs Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 49. World Single Domain Antibody(sdAbs) Drugs Production Value Market Share by Sales Channels in 2025
Figure 50. Online Sales
Figure 51. Offline Sales
Figure 52. World Single Domain Antibody(sdAbs) Drugs Production Market Share by Sales Channels (2021-2032)
Figure 53. World Single Domain Antibody(sdAbs) Drugs Production Value Market Share by Sales Channels (2021-2032)
Figure 54. World Single Domain Antibody(sdAbs) Drugs Average Price by Sales Channels (2021-2032) & (US$/Unit)
Figure 55. World Single Domain Antibody(sdAbs) Drugs Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Single Domain Antibody(sdAbs) Drugs Production Value Market Share by Application in 2025
Figure 57. Hospital
Figure 58. Clinic
Figure 59. Other
Figure 60. World Single Domain Antibody(sdAbs) Drugs Production Market Share by Application (2021-2032)
Figure 61. World Single Domain Antibody(sdAbs) Drugs Production Value Market Share by Application (2021-2032)
Figure 62. World Single Domain Antibody(sdAbs) Drugs Average Price by Application (2021-2032) & (US$/Unit)
Figure 63. Single Domain Antibody(sdAbs) Drugs Industry Chain
Figure 64. Single Domain Antibody(sdAbs) Drugs Procurement Model
Figure 65. Single Domain Antibody(sdAbs) Drugs Sales Model
Figure 66. Single Domain Antibody(sdAbs) Drugs Sales Channels, Direct Sales, and Distribution
Figure 67. Methodology
Figure 68. Research Process and Data Source
